期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

激素难治性前列腺癌对多西他赛耐药机制的研究进展 被引量：7

原文传递
导出
摘要 前列腺癌患者起初多数对内分泌治疗有效，经过中位14～30个月后，几乎所有患者都将发展为激素抵抗性前列腺癌（castration—resistantPCa，CRPC），对二线内分泌治疗无效或二线内分泌治疗过程中病变进展的前列腺癌称为激素难治性前列腺癌（hormonerefractoryPCa，HRPC）。对HRPC的治疗一直是前列腺癌治疗的难点。
作者 董隽
机构地区 复旦大学附属华东医院泌尿外科
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2011年第2期138-140,共3页 Chinese Journal of Urology
关键词 激素难治性前列腺癌 耐药机制 多西他赛 内分泌治疗 前列腺癌患者 激素抵抗性 HRPC
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献2

二级参考文献42

  • 1孙忠全,钱伟庆,宋建达.比卡鲁胺治疗雄激素非依赖性前列腺癌[J].中国癌症杂志,2006,16(2):158-159. 被引量：9
  • 2Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T, et al, MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer, Gastroenterology 2007; 133: 647-58,.
  • 3Ribas J, Ni X, Haffner M, Wentzel EA, Salmasi AH, Chowdhury WH, et al. miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res 2009; 69: 7165-9.
  • 4Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008; 27: 2128-36.
  • 5Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, Kashiwagi E, et al. Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth. Cancer Res 2009; 69: 3148-56.
  • 6Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009; 37: 918-25.
  • 7Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007; 282: 14328- 36.
  • 8Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 2008; 19: 3272-82.
  • 9Hilliard A, Hilliard B, Zheng S J, Sun H, Miwa T, Song W, et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4. J Immunol 2006; 177: 8095-102.
  • 10Jansen AP, Camalier CE, Colburn NH. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res 2005; 65: 6034-41.

共引文献21

同被引文献73

  • 1叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量：168
  • 2刘秀峰,秦叔逵,王琳,钱军,陈映霞,何泽明,龚新雷,杨柳青.恩度与化疗联合治疗多种晚期恶性肿瘤的临床观察[J].临床肿瘤学杂志,2007,12(4):241-245. 被引量：144
  • 3武国海,周彩红,王明伟.前列腺癌治疗药物的研究新进展[J].中国新药杂志,2007,16(17):1330-1336. 被引量：4
  • 4PEYROMAURE M, DEBRE B, MAO K, et al. Management of prostate cancer in China: a multicenter report of 6 institu tions[J]. Journal of Urology, 2005,174(5):1794- 1797.
  • 5FOLKMAN J, WATSON K, INGBER D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia[J]. Nature, 1989,339(6219):58-61.
  • 6YAMANAKA K, ROCCHI P, MIYAKE H, et al. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensi- tivity in androgen-independent human prostate cancer PC3 cells[J]. Molecular Cancer Therapeutics, 2005,4 (11) : 1689- 1698.
  • 7SHI Y, CHATTERJEE S J, BRANDS F H, et al. Role of co- ordinated molecular alterations in the development of andro- gen-independent prostate cancer: an in vitro model that cor- roborates clinical observations[J]. BJU International, 2006, 97(1):170 -178.
  • 8LEE J T, STEELMAN L S, MCCUBREY J A. Phosphati- dylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in ad- vanced prostate cancer cells[J]. Cancer Research, 2004,64 (22) : 8397-8404.
  • 9LAM J S,LEPPERT J T,VEMULAPALLI S N,et al.Secondary hormonal therapy for advanced prostate cancer[J].Urol,2006,175(1):27-34.
  • 10FIGG W D Ⅱ,FIGG W D.Cabazitaxel:filling one of the gaps in the treatment of prostate cancer[J].Cancer Biol Ther,2011,10(12):1233-1234.

引证文献7

二级引证文献29

中华泌尿外科杂志
2011年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部